Transatlantic Expansion Tjoapack is actively expanding in the United States and Europe, with recent facility growth in Tennessee and new packaging capabilities in the Netherlands, signaling readiness to scale for cross-border pharmaceutical clients and provide enhanced supply chain coverage.

US Footprint Growth Significant investments in a 170,000-square-foot GMP facility in Tennessee boost high-speed packaging, labeling, cold-chain, and ambient storage capabilities, creating opportunities to onboard large US-based pharma and biotech customers seeking reliable domestic packaging and distribution support.

End-to-End Logistics With EU-GMP and FDA certifications, serialization and aggregation expertise, stock management, and cold-chain capabilities, Tjoapack can position itself as a single-source partner for complex supply chains including biotech, clinical trial, controlled substances, and orphan drugs.

Digital Collaboration The Customer Collaboration Dashboard launched in 2025 enhances artwork management, file exchange, workflow creation, and order visibility, offering a compelling value proposition for customers seeking transparent, efficient, and scalable packaging programs.

Strategic Ownership Industry investment history by Ampersand Capital Partners and 2026 acquisition discussions indicate strategic backing and potential for accelerated international integration, suggesting upsell opportunities in expanded service tiers and integration with client systems.